Performance Nutrition Firm Secures $2.1M in Annual Sales

Sponsored:

Monday, May 4, 2026

The sports nutrition market remains one of the most consistent growth stories in consumer health, with the global sector projected to reach USD $108 billion by 2034 (IMARC Group). Within this space, the proteins and amino acids segment stands as the largest category, driven by a growing awareness of muscle repair and recovery. In an increasingly crowded market, clinically validated formulas with differentiated efficacy data carry a significant advantage over commodity protein powders. Today, a performance nutrition specialist reported a triple-digit revenue surge that suggests its science-led commercial strategy is gaining serious market traction.

Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) reported audited fiscal 2025 results showing revenue of over $2.1M, a 700% increase compared to $260,600 in 2024. Alongside the revenue growth, the company successfully executed a cost-reduction strategy, with total expenses falling from $6.3M to $3.4M. This dual momentum resulted in a significantly narrowed net loss of $3.0M, down from $7.1M the prior year.

The primary growth driver is Rejuvenate Muscle Health, a proprietary, clinically researched amino acid formula designed to rebuild and restore muscle tissue. Demand in 2025 was bolstered by expansion across both e-commerce and retail channels as muscle health emerges as a distinct wellness category. To support this accelerating momentum, the company has initiated a major production run of more than 3.5M servings across four flavors, including Mango and Grape.

Beyond the top-line growth, the company has focused on strengthening its corporate foundation. Following the revocation of a 2025 cease-trade order, management implemented enhanced internal controls and financial reporting processes. This included a restatement of 2024 financials to improve transparency regarding share-based payments and liability timing. CEO Vito Sanzone noted that these investments in financial infrastructure are intended to position the company for a higher standard of accountability as it scales.

MUSL / MUSLF is trading at C$0.045 and US$0.026, up 12.50% and flat, respectively, on today’s session. Investors will be watching the first half of 2026 to see how effectively the new inventory translates into sustained commercial growth.

Sponsored: